<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - BMTI</title>
<description>International Business News - BMTI</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Movers Roundup: Bed Bath &amp; Beyond</title>
  <description>Among the stock activity stories for Friday, March 28, from AP Financial News: NEW YORK (AP) _ Shares of Bed Bath &amp; Beyond Inc. fell after an analyst downgraded the home-furnishings retailer based on tougher competition and a difficult retail environment.</description>
    <link>http://www.ibtimes.com/articles/20080328/movers-roundup-bed-bath-beyond.htm</link> 
  <pubDate>Fri, 28 Mar 2008 18:35:00 EDT</pubDate>
  </item>


  <item>
  <title>BioMimetic Up Despite FDA Note</title>
  <description>Shares of BioMimetic Therapeutics Inc. surged Friday as Wall Street brushed off anxiety over Food and Drug Administration concerns linking a competitor's diabetic foot ulcer treatment to higher cancer risk.</description>
    <link>http://www.ibtimes.com/articles/20080328/biomimetic-up-despite-fda-note.htm</link> 
  <pubDate>Fri, 28 Mar 2008 17:24:44 EDT</pubDate>
  </item>


  <item>
  <title>BioMimetic Disputes Study on Cancer Risk</title>
  <description>BioMimetic Therapeutics Inc. said late Thursday that there appears to be inconsistent data in a study referenced by the Food and Drug Administration on cancer risks related to the company's diabetic foot ulcer treatment.</description>
    <link>http://www.ibtimes.com/articles/20080328/biomimetic-disputes-study-on-cancer-risk.htm</link> 
  <pubDate>Fri, 28 Mar 2008 09:49:01 EDT</pubDate>
  </item>


  <item>
  <title>BioMimetic Stock Up Ahead of 2007 Report</title>
  <description>Shares of BioMimetic Therapeutics are rising ahead of the medical products maker's full-year earnings report. The company is developing products that combine drugs with medical devices to promote faster growth and healing of tissue. Wall Street thinks the Franklin, Tenn., company will report a loss of $1.30 per share on almost $8 million in sales.</description>
    <link>http://www.ibtimes.com/articles/20080312/biomimetic-stock-up-ahead-of-2007-report.htm</link> 
  <pubDate>Wed, 12 Mar 2008 13:09:14 EDT</pubDate>
  </item>


</channel>
</rss>